Here's a summary of Viyash Scientific Limited's Q1 FY27 performance, tailored for retail investors: **Business Performance:** Viyash Scientific reported a strong Q1 FY27 with revenues climbing by 19.5% YoY to ₹9,464 Million. This growth was primarily driven by the Formulations segment, which saw a 33% YoY increase, and robust performance...
Here's a summary of Viyash Scientific's investor presentation, tailored for retail investors: **1. Business Performance:** Viyash Scientific delivered a strong FY26, with Q4 being its best quarter ever. Revenues grew 13.8% YoY to ₹34,203 Cr for the full year, driven by robust performance in Formulations (+18% YoY) and APIs (+8%...
